Project Objectives
The project aims at investigating the potential role of different InMed Pharmaceuticals proprietary compounds on the modulation of the various elements of the endocannabinoid system in human keratinocytes, in order to use them as a new therapeutical strategy to cure skin conditions like tumors, psoriasis, atopic dermatitis, acne vulgaris, seborrhea and itchy skin.
Start/End date
2019 - 2021
Principal Investigator
Prof. Mauro Maccarrone - Coordinator
Host Institution
Campus Bio-Medico University of Rome
Other Institutions involved
- Università degli Studi di Teramo
Source of funding
InMed Pharmaceuticals Inc. (Canada)